Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL

International Immunopharmacology

Volumn 4, Issue 9, 2004, Pages 1201-1207

  Mizunoe, Syunji ^a   Kadota, Jun Ichi ^a   Tokimatsu, Issei ^a   Kishi, Kenji ^a   Nagai, Hiroyuki ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl xL; Fas; FasL; Lymphocytes; Macrolides

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; FAS ANTIGEN; JOSAMYCIN; MACROLIDE; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD95; APOPTOSIS; AZITHROMYCIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELLS, CULTURED; CLARITHROMYCIN; DOWN-REGULATION; FAS LIGAND PROTEIN; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STIMULATION, CHEMICAL;

EID: 3142574652     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.05.011     Document Type: Article

References (29)

1. Kudoh S., Azuma A., Yamamoto M., Izumi T., Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am. J. Respir. Crit. Care Med. 157:1998;1829-1832
2. Oishi K., Sonoda F., Kobayashi S., Matsumoto K. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airway of patients with chronic airway diseases. Infect. Immun. 62:1994;4145-4152
3. Sakito O., Kadota J., Kohno S., Abe K., Shirai R., Hara K. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration. 63:1996;42-48
4. Takizawa H., Daesaki M., Ohtoshi T., Kikutani T., Okazaki H., et al. Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cell: A potential mechanism of its anti-inflammatory action. Biochem. Biophys. Res. Commun. 210:1995;781-786
5. Takizawa H., Daesaki M., Ohtoshi T., Kawasaki S., Kohyama T., et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 156:1997;266-271
6. Homma H., Yamanaka A., Tanimoto S., Tamura M., Chijimatsu Y., et al. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest. 83:1983;63-69
7. Iwata M., Colby T.V., Kitaichi M. Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations. Hum. Pathol. 25:1994;357-363
8. Kawakami K., Kadota J., Iida K., Fujii T., Shirai R., et al. Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells. Clin. Exp. Immunol. 107:1997;410-416
9. Mukae H., Kadota J., Kohno S., Kusano S., Morikawa T., et al. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am. J. Respir. Crit. Care Med. 152:1995;613-618
10. Sato A., Chida K., Iwata M., Hayakawa H. Study of bronchus-associated lymphoid tissue in patients with diffuse panbronchiolitis. Am. Rev. Respir. Dis. 146:1992;473-478
11. Keicho N., Kudoh S., Yoshimoto H., Akagawa K.S. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J. Antibiot. 46:1993;1406-1413
12. Kadota J., Mukae H., Tomono K., Kohno S. High concentrations of β-chemokines in BAL fluid of patients with diffuse panbronchiolitis. Chest. 120:2001;602-607
13. Hashimoto Y., Matsuoka N., Kawakami A., Tsuboi M., Nakashima T., et al. Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis. Clin. Exp. Immunol. 125:2001;19-24
14. Yamada T., Hashimoto T., Sogawa M., Kobayashi S., Kaneda K., et al. Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus. Am. J. Physiol.: Gastrointest Liver Physiol. 281:2001;1397-1404
15. Todate A., Chida K., Suda T., Imokawa S., Sato J., et al. Increased numbers of dendritic cells in the bronchiolar tissues of diffuse panbronchiolitis. Am. J. Respir. Crit. Care Med. 162:2000;148-153
16. Kadota J., Sakito O., Kohno S., Sawa H., Mukae H., et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am. Rev. Respir. Dis. 147:1993;153-159
17. Miyawaki T., Uehara T., Nibu R., Tsuji T., Yachie A., et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:1992;3753-3758
18. Robertson M.J., Manley T.J., Pichert G., Cameron C., Cochran K.J., et al. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk. Lymphoma. 17:1995;51-61
19. Tanaka M., Suda T., Takahashi T., Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J. 14:1995;1129-1135
20. Laux I., Khoshnan A., Tindell C., Bae D., Zhu X., et al. Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Clin. Immunol. 96:2000;187-197
21. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619
22. Yang E., Korsmeyer S.J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88:1996;386-401
23. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., et al. CD28 costimulation can promote T cell survival by enhancing the expression of bcl-xL. Immunity. 3:1995;87-98
24. Fraser J.D., Irving B.A., Crabtree G.R., Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science. 251:1991;313-316
25. Noel P.J., Boise L.H., Green J.M., Thompson C.B. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:1996;636-642
26. Schwartz R.H. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71:1992;1065-1068
27. Rodvold K.A., Gotfried M.H., Danziger L.H., Servi R.J. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob. Agents Chemother. 41:1997;1399-1402
28. Kadota J., Ishimatsu Y., Iwashita T., Matsubara Y., Tomono K., et al. Intrapulmonary phramacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers. Antimicrob. Agents Chemother. 46:2002;917-921
29. Muller-Serieys C., Andrews J., Vacheron F., Cantalloube C. Tissue kinetics of telithromycin, the first ketolide antibacterial. J. Antimicrob. Chemother. 53:2004;149-157